Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2334 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-17

Study Completion Date

2017-04-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to describe the long-term antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome in China.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia

NCT01361386

Acute Coronary Syndrome

COMPLETED

Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation

NCT03051061

Atrial Fibrillation Coronary Heart Disease

UNKNOWN

Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS

NCT02415803

Non ST Segment Elevation Acute Coronary Syndrome

UNKNOWN PHASE3

Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.

NCT05718531

Coronary Artery Ectasia

UNKNOWN PHASE3

Follow up of Ticagrelor Treatment Patterns in Chinese Acute Coronary Syndromes Patients

NCT04861363

Acute Coronary Syndrome

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is to describe the long-term (3 to 5 years after the acute coronary syndrome index event) antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome (i.e. ST-segment Elevation Myocardial Infarction, Non-ST-segment Elevation Myocardial Infarction, Unstable Angina) in China.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndromes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Written informed consent has been provided.
2. Contact Order Form has been provided
3. Aged 18 years or older.
4. Enrolled in EPICOR Asia study and completed the 2 year follow-up.

Exclusion Criteria

1. Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances, alcohol or drug abuse).
2. Already included in the EPICOR Asia-China Extension observational study.
3. Presence of serious/severe co-morbidities in the opinion of the investigator which may limit short term (i.e. 6 month) life expectancy.
4. Current participation in an interventional clinical trial.
5. Patients receiving ticagrelor beyond 12 months and other off label use.

Eligible Sex

ALL

Accepts Healthy Volunteers

No